Back to results
US 12,180,216 B2Granted
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing GABAA receptor agonists
AssigneeUWM Research Foundation, Inc.
InventorsJames M. Cook, Guanguan Li, Michael Ming-Jin Poe, Miroslav M. Savic, Etienne Sibille
Life of this patent
Estimating the term…
Abstract
Provided herein are alpha5-containing GABAA receptor agonists and pharmaceutical compositions and methods of treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders using them.
Claims12
A method of treating cognitive and/or mood symptoms in a subject in need thereof, comprising administering a compound having a structure of
- or a pharmaceutically acceptable salt thereof, to the subject.
A compound having a structure
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.